Vaccine presentations and delivery technologies - What does the future hold?

Expert Review of Vaccines

Volumn 4, Issue 3, 2005, Pages 281-287

  Clements, C John ^a   Wesselingh, Steve L ^a  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXOID; DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; RABIES VACCINE; SMALLPOX VACCINE; TETANUS TOXOID; VACCINE; YELLOW FEVER VACCINE;

DEVELOPED COUNTRY; DISPOSABLE EQUIPMENT; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; DRUG STABILITY; DRUG SYNTHESIS; HEALTH CARE ORGANIZATION; HEAT TOLERANCE; HUMAN; INSTRUMENT STERILIZATION; NEEDLE; NEEDLESTICK INJURY; NONHUMAN; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SYRINGE; THERMOSTABILITY; UNITED NATIONS; VACCINATION; WORLD HEALTH ORGANIZATION;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; TECHNOLOGY, PHARMACEUTICAL; VACCINES;

EID: 22144469129     PISSN: 14760584     EISSN: None     Source Type: Journal    
DOI: 10.1586/14760584.4.3.281     Document Type: Review

References (28)

1. Bland J, Clements CJ. Protecting the world's children: the story of WHO's immunization programme. World Health Organization Forum 19(2), 162-173 (1998).
2. Jodar L, Clements CJ, Duclos P, Milstien JB. Ensuring vaccine safety in immunization programmes - a WHO perspective. Vaccine 19, 1594-1605 (2001).
3. Kane A, Lloyd JK, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and human immunodeficiency virus through unsafe injections in the developing world: model-based regional estimates. Bull. World Health Organization 77, 801-807 (1999). The risk associated with injections were modelled and predicted by simple extrapolation from available data. The study was not confined to immunization services, although immunization was identified as being a potential risk.
4. Hutin YJF, Chen RT. Injection safety: a global challenge. Bull. World Health Organization 77, 787-788 (1999).
5. Andrews N, Miller E, Grant A, Stowe J, Osbourne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 114(3), 584-591 (2004).
6. Clements CJ. The evidence for the safety of thiomersal in newborn and infant vaccines. Vaccine 22(15-16), 1854-1861 (2004).
7. Phadke MA, Joshi BN, Warekar UV et al. Toxic shock syndrome: an unforeseen complication following measles vaccination. Indian Pediatr. 28, 663-665 (1991).
8. Andre FE. Thermodegradation of lyophilized measles vaccine. Rev. Infect. Dis. 5, 532-534 (1983).
9. Cohen H, Bos JM. The influence of storage at 37°C on the potency of freeze dried and reconstituted live measles vaccine. Proceedings of the Symposium on Stability and Effectiveness of Measles, Poliomyelitis and Pertussis Vaccines. Yugoslav Academy of Sciences and Arts, Zagreb, Yugoslavia, 95-101 (1976).
10. Finter NB. Effects of adverse storage on live virus vaccines. Dev. Biol. Stand. 41, 271-276 (1978).
11. Krugman RD, Meyer BC, Enterline JC, Parkman PD, Witte JJ, Meyer HM Jr. Impotency of live virus vaccines as a result of improper handling in clinical practice. J. Pediatr. 85, 512-514 (1974).
12. Vaccine vial monitors take guesswork out of immunization. Vaccine Immunology News June(1), 7-8 (1996).
13. Nelson CM, Wibisono H, Purwanto H, Mansyur I, Moniaga V, Widjaya A. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions. Bull. World Health Organization 82(2), 99-105 (2004).
14. Clements CJ, Aguado MT, Jodar L. Technologies to improve immunization safety. Drug Safety 24(14), 1019-1026 (2001).
15. Drain PK, Nelson CM, Lloyd JS. Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries. Bull. World Health Organization 81(10), 726-731 (2003). Presents a programmatic and economic comparison of the major differences between multidose and single-dose vials, with special reference to their use in developing country programs. Concludes that multidose formats are likely to be the most appropriate for cheaper vaccines and in settings where cold-chain storage capacity is restricted, and single-dose formats will be favored where there are problems with unsafe injection practices or for the more expensive vaccines.
16. Cutts FT, Clements CJ, Bennett JV. Alternative routes of measles immunization: a review. Biologicals 25, 323-338 (1997).
17. Webster DE, Gahan ME, Strugnell RA, Wesselingh SL. Advances in oral vaccine delivery options: what is on the horizon? Am. J. Drug Deliv. 1(4), 227-240 (2003).
18. Sabin AB, Flores Arechiga A, Fernandez de Castro J, Albrecht P, Sever JL, Shekarchi I. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine (II) Vaccine comparisons and evidence for multiple antibody response. JAMA 251(18), 2363-2371 (1984). Describes the use of an aerosolized inhaled measles vaccine as one possible means other than needle and syringe for administering measles vaccine in a mass campaign. School children receiving the vaccine showed excellent seroconversion rates.
19. Partidos CD. Delivering vaccines into the skin without needles and syringes. Expert Rev. Vaccines 2(6), 753-761 (2003).
20. Steinglass R, Grabowsky M, Laghari AG et al. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country. Bull. World Health Organization 73, 57-63 (1995).
21. Janouskova O, Nellessen T, Stokrova J, Jinoch P, Smahel M. Delivery of recombinant adeno-associated virus by jet injection. Int. J. Mol. Med. 12(5), 687-691 (2003).
22. Williams J, Fox-Leyva L, Christensen C, et al. Hepatitis A vaccine administration: comparison between jet-injector and needle injection. Vaccine 18(18), 1939-1943 (2000).
23. Aguado T, Jodar L, Lloyd J, Lambert PH. Injectable solid vaccines: a role in future immunization? World Health Organization Drug Inf. 12, 68-69 (1998).
24. Ministry of Health, Indonesia. Achieving Universal Childhood Immunization with Hepatitis B Vaccine: Policy and Cost-effectiveness Issues. Ministry of Health of Indonesia in cooperation with the Program for Appropriate Technology in Health, PATH, April (1996).
25. Sutanto A, Suwarna IM, Nelson CM, Stewart T, Seowarso TI. Home delivery of heat-stable vaccines in Indonesia: outreach immunization with pre-filled, single-use injection devices. Bull. World Health Organization 77(2), 119-126 (1999).
26. Soewarso TI, Widjaya A, Saleh A. Early Integrated Efforts for Maternal and Child Survival Ministry of Health of Indonesia in cooperation with the Program for Appropriate Technology in Health, PATH (1996).
27. Widjaya A, Saleh A, Purwanto H, Anwar C. Improving the Safety and Effectiveness of Hepatitis B Immunization in Indonesia through Uniject Introduction in DI Yogyakarta, East Java and West Nusa Tenggara Provinces, August 2000-July 2001. Ministry of Health of Indonesia in co-operation with the Program for Appropriate Technology in Health, PATH (2002).
28. Quiroga R, Halkyer P, Gil F, Nelson C, Kristensen D. A prefilled injection device for outreach tetanus immunization by Bolivian traditional birth attendants. Rev. Panam. Salud. Publica/Pan. Am. J. Public Health 4(1), (1998).